Representatives of US pharmacist and drug store groups had the floor for an hour recently at the Food and Drug Administration to make recommendations they’ve also made in comments submitted to the agency about making more drugs available OTC.
The groups’ representatives, in a meeting with FDA officials on 15 November, reiterated their general argument about the agency’s “additional...